[ Université de Bordeaux, 35 place Pey Berland, Bordeaux]
The EORTC Breast Cancer Group Autumn meeting will be held in Bordeaux, France on 29 September 2023. It is only open to individual or site staff members of the group.
| 9.30-10.45 | Session 1 (*): | Moderator: M. Ignatiadis |
| · Finances and updates
· Synopsis of the SAC · Strategies of the group · update on EORTC BCG 2022 and 2023 Retreats |
M. Ignatiadis (Brussels), F. van Duijnhoven (Amsterdam), M. Arnedos (Bordeaux) | |
| 10.45-11.00 | Coffee break | |
| 11.00-13.00 | Session 2 (*): studies in development and proposals |
|
| To be completed | ||
| 13.00-14.00 | Lunch | |
| 14.00-16.00 | Session 3 (*): ongoing studies |
Moderators: M. Ignatiadis, M.Arnedos |
| DECRESCENDO (De-escalation after neoadjuvant trastuzumab, pertuzumab and taxol in HER2-pos. HR-neg. breast cancer with a pCR) | E. Brain (St Cloud, Paris) | |
| NOBLE (EORTC 1984: neoadjuvant olaparib and durvalumab) | E. Brain (St Cloud-Paris) | |
| APPALACHES (Palbociclib in elderly pts) | H. Wildiers (Leuven) | |
| TREAT ctDNA (Elacestrant) | M. Ignatiadis (Brussels) | |
| 16.00-16.15 | Coffee break | |
| 16.15-18.30 | Session 4:
The future of Academic Research in Europe |
Moderators: G. Mac Grogan, (other tbc) |
| Clinical research in elderly patients | E. Brain (St Cloud-Paris) | |
| Machine learning-based and multiplexed resolution in early breast cancer | T. Foukakis (Stockholm) | |
| The assessment of cosmetic outcomes after reconstruction and its impact on choice (CINDERELLA) | M.J. Cardoso (Lisboa) | |
| Locoregional surgery after primary endocrine therapy | F. van Duijnhoven (Amsterdam) | |
| Challenging academic research: how to improve EORTC and BIG relationship | D. Cameron (Edinburgh) |
(*) Closed to Industry
